Naltrexone

Last Updated: 04/28/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17516 publications

Correction to: Exploring the association between sweet liking and treatment response to naltrexone in patients with alcohol use disorder.

Correction to: Exploring the association between sweet liking and treatment response to naltrexone in patients with alcohol use disorder.

Journal: The international journal of neuropsychopharmacology

Published: April 14, 2026

The Efficacy of Olanzapine/Samidorphan on Negative Symptoms: A Post Hoc Analysis of 56-Week Treatment in Patients With Schizophrenia.

The Efficacy of Olanzapine/Samidorphan on Negative Symptoms: A Post Hoc Analysis of 56-Week Treatment in Patients With Schizophrenia.

Journal: The Journal of clinical psychiatry

Published: April 07, 2026

Patient Characteristics Associated with Successful Initiation of Extended-Release Naltrexone in the X:BOT Trial.

Patient Characteristics Associated with Successful Initiation of Extended-Release Naltrexone in the X:BOT Trial.

Journal: Substance use & misuse

Published: April 03, 2026

Association Between Medication for Alcohol Use Disorder and Confirmed Linkage to Care Following Discharge From an Inpatient Unit for Medically Managed Withdrawal.

Association Between Medication for Alcohol Use Disorder and Confirmed Linkage to Care Following Discharge From an Inpatient Unit for Medically Managed Withdrawal.

Journal: Substance use & addiction journal

Published: April 02, 2026

Regional Blood Flow Signatures of Opioidergic Modulation of Ketamine in Major Depressive Disorder: A Randomized Crossover Study.

Regional Blood Flow Signatures of Opioidergic Modulation of Ketamine in Major Depressive Disorder: A Randomized Crossover Study.

Journal: The American journal of psychiatry

Published: April 02, 2026

Recommendations from the Clinical Toxicology Recommendations Collaborative on the administration of activated charcoal in acute oral overdose.

Recommendations from the Clinical Toxicology Recommendations Collaborative on the administration of activated charcoal in acute oral overdose.

Journal: Clinical toxicology (Philadelphia, Pa.)

Published: March 30, 2026

Local therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids.

Local therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids.

Journal: The Journal of dermatological treatment

Published: March 26, 2026

Pharmacological post-acute treatment of alcohol use disorder: Established strategies and innovative approaches

Pharmacological post-acute treatment of alcohol use disorder: Established strategies and innovative approaches

Journal: Therapeutische Umschau. Revue therapeutique

Published: March 25, 2026

Drugs for dementia.

Drugs for dementia.

Journal: The Medical letter on drugs and therapeutics

Published: March 24, 2026

Protective effect of concurrent bupropion and citicoline treatment on lipopolysaccharide-induced depression- and anxiety-like behavior in mice: The role of neuroinflammation.

Protective effect of concurrent bupropion and citicoline treatment on lipopolysaccharide-induced depression- and anxiety-like behavior in mice: The role of neuroinflammation.

Journal: Experimental and clinical psychopharmacology

Published: March 23, 2026

Sustained-Release Naltrexone for Opioid Dependence.

Sustained-Release Naltrexone for Opioid Dependence.

Journal: American family physician

Published: March 16, 2026

Severe Early-Onset Withdrawal Following Intentional Use of Mitragynine Pseudoindoxyl: A Case Report and Emerging Clinical Considerations.

Severe Early-Onset Withdrawal Following Intentional Use of Mitragynine Pseudoindoxyl: A Case Report and Emerging Clinical Considerations.

Journal: Cureus

Published: March 14, 2026

Showing 1-12 of 17,516

Last Updated: 04/28/2026